F E I Company (FEIC) 106.78 $FEIC
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 41.89 (+0.53), JNJ: 122.85 (+0.34), ZBH: 124.89 (+2.87), LDRH: 36.97 (-0.01), MDT: 88.36 (+0.87), TMO: 152.69 (+3.63), STJ: 80.58 (+0.43), HTWR: 57.64 (+0.11), XRAY: 63.39 (+0.89), NUVA: 60.82 (+1.11), FEIC: 106.78 (-0.23)
FEI Launches Helios G4 DualBeam Series for Materials Science
GlobeNewswire - Mon Jun 27, 7:15AM CDT
FEI (NASDAQ:FEIC) continues to lead the industry with the launch of the Helios(TM) G4 DualBeam Series for materials science, offering highly automated and precise sample preparation for transmission electron microscopy (TEM) and three-dimensional (3D) sample characterization. The Helios G4 features FEI's most advanced scanning electron microscope (SEM) and focused ion beam (FIB) technology with a new level of automation and ease-of-use.
FEIC: 106.78 (-0.23)
Lifshitz & Miller Law Firm Announces Investigation of ChromaDex Corporation, CPI Card Group Inc., Electro Rent Corporation, Elizabeth Arden, Inc., Envision Healthcare Holdings, Inc., FEI Company, Polonia Bancorp, Inc., and SciQuest, Inc.
PR Newswire - Tue Jun 21, 12:19PM CDT
ChromaDex Corporation (CDXC)
EVHC: 25.70 (+0.66), RDEN: 13.87 (+0.05), PMTS: 4.75 (-0.08), SQI: 17.74 (+0.08), CDXC: 3.94 (+0.13), ELRC: 15.45 (+0.05), FEIC: 106.78 (-0.23)
FEI Announces Quarterly Cash Dividend of $0.30 per Share
GlobeNewswire - Thu Jun 09, 3:05PM CDT
FEI Company (NASDAQ:FEIC) announced that its board of directors has approved payment of a quarterly dividend of $0.30 per share of common stock. The dividend will be paid on July 20, 2016 to shareholders of record as of the close of business on July 7, 2016.
FEIC: 106.78 (-0.23)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of FEI Company
BusinessWire - Tue Jun 07, 9:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of FEI Company ("FEIC" or "the Company"
(Nasdaq: FEIC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Thermo Fischer Scientific Inc. ("Thermo Fischer".
FEIC: 106.78 (-0.23)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of FEI Company to Thermo Fisher Scientific Inc.
BusinessWire - Mon Jun 06, 2:04PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FEIC: 106.78 (-0.23)
FEI Company Acquisition May Not Be in the Best Interests of FEIC Shareholders
PR Newswire - Fri Jun 03, 2:48PM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of FEI Company ("FEIC" or the "Company" in connection with the proposed acquisition of the Company by Thermo Fisher Scientific Inc. ("Thermo Fisher". On May 27, 2016, the Company announced it had reached a definitive agreement for Thermo Fisher to acquire all outstanding shares of FEIC for $107.50 in cash for each share of Company common stock.
FEIC: 106.78 (-0.23)
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of FEI Company And Encourages Shareholders To Contact The Firm For Additional Information
BusinessWire - Thu Jun 02, 4:27PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of FEI Company (Nasdaq: FEIC) ("FEI" or the "Company" relating to the proposed buyout of FEI by Thermo Fisher Scientific Inc.
FEIC: 106.78 (-0.23)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 41.89 (+0.53), JNJ: 122.85 (+0.34), ZBH: 124.89 (+2.87), LDRH: 36.97 (-0.01), MDT: 88.36 (+0.87), TMO: 152.69 (+3.63), STJ: 80.58 (+0.43), HTWR: 57.64 (+0.11), XRAY: 63.39 (+0.89), NUVA: 60.82 (+1.11), FEIC: 106.78 (-0.23)
FEI Launches Helios G4 DualBeam Series for Materials Science
GlobeNewswire - Mon Jun 27, 7:15AM CDT
FEI (NASDAQ:FEIC) continues to lead the industry with the launch of the Helios(TM) G4 DualBeam Series for materials science, offering highly automated and precise sample preparation for transmission electron microscopy (TEM) and three-dimensional (3D) sample characterization. The Helios G4 features FEI's most advanced scanning electron microscope (SEM) and focused ion beam (FIB) technology with a new level of automation and ease-of-use.
FEIC: 106.78 (-0.23)
Lifshitz & Miller Law Firm Announces Investigation of ChromaDex Corporation, CPI Card Group Inc., Electro Rent Corporation, Elizabeth Arden, Inc., Envision Healthcare Holdings, Inc., FEI Company, Polonia Bancorp, Inc., and SciQuest, Inc.
PR Newswire - Tue Jun 21, 12:19PM CDT
ChromaDex Corporation (CDXC)
EVHC: 25.70 (+0.66), RDEN: 13.87 (+0.05), PMTS: 4.75 (-0.08), SQI: 17.74 (+0.08), CDXC: 3.94 (+0.13), ELRC: 15.45 (+0.05), FEIC: 106.78 (-0.23)
FEI Announces Quarterly Cash Dividend of $0.30 per Share
GlobeNewswire - Thu Jun 09, 3:05PM CDT
FEI Company (NASDAQ:FEIC) announced that its board of directors has approved payment of a quarterly dividend of $0.30 per share of common stock. The dividend will be paid on July 20, 2016 to shareholders of record as of the close of business on July 7, 2016.
FEIC: 106.78 (-0.23)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of FEI Company
BusinessWire - Tue Jun 07, 9:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of FEI Company ("FEIC" or "the Company"
(Nasdaq: FEIC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Thermo Fischer Scientific Inc. ("Thermo Fischer". FEIC: 106.78 (-0.23)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of FEI Company to Thermo Fisher Scientific Inc.
BusinessWire - Mon Jun 06, 2:04PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FEIC: 106.78 (-0.23)
FEI Company Acquisition May Not Be in the Best Interests of FEIC Shareholders
PR Newswire - Fri Jun 03, 2:48PM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of FEI Company ("FEIC" or the "Company"
in connection with the proposed acquisition of the Company by Thermo Fisher Scientific Inc. ("Thermo Fisher". On May 27, 2016, the Company announced it had reached a definitive agreement for Thermo Fisher to acquire all outstanding shares of FEIC for $107.50 in cash for each share of Company common stock. FEIC: 106.78 (-0.23)
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of FEI Company And Encourages Shareholders To Contact The Firm For Additional Information
BusinessWire - Thu Jun 02, 4:27PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of FEI Company (Nasdaq: FEIC) ("FEI" or the "Company"
relating to the proposed buyout of FEI by Thermo Fisher Scientific Inc. FEIC: 106.78 (-0.23)
